Emerging Therapies for Hepatocellular Carcinoma (HCC)

por Chakraborty, Eesha, Sarkar, Devanand
Publicado 2022

BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer

por Elshazly, Ahmed M., Sinanian, Melanie M., Neely, Victoria, Chakraborty, Eesha, Alshehri, Muruj A., McGrath, Michael K., Harada, Hisashi, Schoenlein, Patricia V., Gewirtz, David A.
Publicado 2023

The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells

por Softah, Abrar, Alotaibi, Moureq R., Alhoshani, Ali R., Saleh, Tareq, Alhazzani, Khalid, Almutairi, Mashal M., AlRowis, Raed, Alshehri, Samiyah, Albekairy, Norah A., Harada, Hisashi, Boyd, Rowan, Chakraborty, Eesha, Gewirtz, David A., As Sobeai, Homood M.
Publicado 2023